Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Capital Employed (2021 - 2025)

Rani Therapeutics Holdings has reported Return on Capital Employed over the past 5 years, most recently at 1.76% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 1.76% for Q4 2025, up 88.0% from a year ago — trailing twelve months through Dec 2025 was 1.76% (up 88.0% YoY), and the annual figure for FY2025 was 1.1%, up 85.0%.
  • Return on Capital Employed for Q4 2025 was 1.76% at Rani Therapeutics Holdings, down from 7.95% in the prior quarter.
  • Over the last five years, Return on Capital Employed for RANI hit a ceiling of 441.93% in Q2 2025 and a floor of 5.0% in Q1 2025.
  • Median Return on Capital Employed over the past 5 years was 0.75% (2023), compared with a mean of 23.78%.
  • Peak annual rise in Return on Capital Employed hit 44373bps in 2025, while the deepest fall reached -350bps in 2025.
  • Rani Therapeutics Holdings' Return on Capital Employed stood at 0.4% in 2021, then plummeted by -52bps to 0.61% in 2022, then crashed by -92bps to 1.18% in 2023, then crashed by -124bps to 2.64% in 2024, then surged by 33bps to 1.76% in 2025.
  • The last three reported values for Return on Capital Employed were 1.76% (Q4 2025), 7.95% (Q3 2025), and 441.93% (Q2 2025) per Business Quant data.